Targeting Adolescent Insomnia to Lessen Overall Risk of Suicidal Behavior

Status: Recruiting
Location: See location...
Intervention Type: Behavioral, Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study will test the effectiveness of a sleep-related primary suicide prevention program entitled TAILOR (Targeting Adolescent Insomnia to Lessen Overall Risk of Suicidal Behavior), which includes specific behavior-change strategies for adolescents at risk of suicidal behavior who suffer from difficulties falling asleep, staying asleep, and/or insufficient sleep.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 11
Maximum Age: 18
Healthy Volunteers: f
View:

• Nationwide Children's Hospital patients

• Between the ages of 11 years, 0 months, and 18 years, 11 months, inclusive at time of consent

• Endorse both recent (past 90 days) suicidal ideation and sleep problems (past 30 days)

• Resides with primary caregiver who has legal authority to consent to research participation

Locations
United States
Ohio
Nationwide Children's Hospital
RECRUITING
Columbus
Contact Information
Primary
Elizabeth Cannon, MA, MS
elizabeth.cannon@nationwidechildrens.org
614-355-0578
Backup
Kendra Heck, MPH
kendra.heck@nationwidechildrens.org
614-355-3433
Time Frame
Start Date: 2022-10-20
Estimated Completion Date: 2026-07
Participants
Target number of participants: 190
Treatments
Experimental: TAILOR
Half of the participants will be randomized into the experimental arm of this study. A study clinician will call each family approximately 4 times over 2 months. The study clinician will conduct suicide risk screening and further assessment and safety planning where deemed necessary. The TAILOR intervention will then be administered. TAILOR includes the assessment of existing sleep problems and sleep practices and education on Cognitive Behavioral Therapy (CBT) strategies for insomnia, with Motivational Interviewing (MI) as the communication style.
Other: Enhanced Usual Care (EUC)
Half of the participants will be randomized into Enhanced Usual Care (EUC). A study clinician will call each family approximately 4 times over 2 months. The study clinician will conduct suicide risk screening and further assessment and safety planning where deemed necessary.
Related Therapeutic Areas
Sponsors
Collaborators: Centers for Disease Control and Prevention
Leads: Jeff Bridge

This content was sourced from clinicaltrials.gov